The NPTMT Core provides diagnostic expertise, facilitates research, teaches and mentors trainees, and develops innovative research approaches to Alzheimer’s disease. Members of the NPTMT Core examine targeted spinal fluid biomarkers in the UW ADRC spinal fluid bank and provide targeted genetic testing relevant to Alzheimer’s and related neurodegenerative diseases that cause dementia. In other words, the NPTMT Core seeks ways to enhance the research value of tissue and body fluid donations from cognitively healthy individuals and patients so that researchers may begin to develop effective means of precision medicine for neurodegenerative diseases.
Aim 1: Provide diagnostic expertise to physicians and researchers with timely and comprehensive autopsy reports that describe the neuropathologic features of AD and related diseases according to the most current guidelines and consensus diagnostic criteria.
Aim 2: Provide targeted cerebrospinal fluid (CSF) biomarker and genetic testing using contemporary techniques on specimens provided by the Clinical Core to enhance the research value of these cases for UW ADRC and other research projects.
Aim 3: Build a highly accessible, and appropriately safeguarded, repository of brain tissue, biological fluids, and neuropathologic data from carefully and longitudinally characterized patients with cognitive impairment or dementia, as well as cognitively normal individuals, using methods that maximize tissue and data quality.
Aim 4: Advance innovative Histelide approaches to rigorously quantify specific molecules in formalin-fixed, paraffin-embedded (FFPE) brain regions to enhance the research value of the full UW ADRC repository, as well as FFPE tissue in other brain banks.
Aim 5: Maintain a rich training environment for medical and graduate students, residents, fellows, and junior faculty to teach concepts and state-of-the-art techniques that advance current interdisciplinary research and foster future advances in brain aging and neurodegeneration. The NPMT Core holds:
- The Clinicopathological Correlation Conference every third Friday from 9-10 am in the Research & Teaching Building at Harborview Medical Center. Dr. Dirk Keene and his colleagues present cases of interest to neuropathological and genetic research and lead a group discussion about new insights into the relationship between neuropathology, genetics, clinical disease manifestation.
The monthly Brain Aging and Neurodegeneration Research in Progress Seminar. This conference is held monthly on the first Friday at 9:00 am at Harborview.
The seminar is an opportunity for graduate students, fellows, and junior faculty to present their research in progress. Talks are designed to provide a supportive environment for trainees to learn to present scientific data and ideas, to receive feedback on research projects, hypotheses, and experimental designs, and to promote interactions between the brain aging and neurodegeneration scientific community and trainees. All who are interested are welcome and encouraged to attend. Please email email@example.com if you'd like to be added to the seminar email list.
July 7, 2017 - conference cancelled
Aug 4, 2017, 9:00 AM - 10:00 AM Maleng Building 111/112
Sep 1, 2017, 9:00 AM - 10:00 AM Research & Training 113
Oct 6, 2017, 9:00 AM - 10:00 AM Research & Training 113
Nov 3, 2017, 9:00 AM - 10:00 AM Research & Training 113
Dec 1, 2017, 9:00 AM - 10:00 AM Research & Training 113
►Learn about the available resources from the Neuropathology & Targeted Molecular Testing Core